Diabetic Eye Disease

Regeneron’s High-Dose Eylea Demonstrates Persistence as FDA Decision Looms

While awaiting an FDA decision regarding a higher-dose version of Eylea (aflibercept), Regeneron has consistently emphasized the durability of their ...